---
figid: PMC6565468__nihms-1021454-f0002
figlink: pmc/articles/PMC6565468/figure/F1/
number: F1
caption: A) Multipotent NSCs have capability to self-renew and differentiate into
  different fate-restricted progenitors. Under genetic and epigenetic alterations,
  these progenitor cells could be transformed into malignant tumors including gliomas
  from NSC, OPC or APC as well as medulloblastomas from NPCs.B) A hierarchical model
  for tumor cell evolution and plasticity to generate distinct tumor-forming cells
  and tumor heterogeneity gained after tumor initiation.C) Malignant transformation
  of GBM is the result of different driver pathway alterations. RTK signaling pathway
  activation mediated by extracellular signal (growth factors, cytokines, and hormones)
  promotes cell cycling for tumorigenesis. Besides, point mutation of histone 3 (H3K27M,
  H3G34R/V) and up-regulation of oncogenic factors, like MYC(N) and AURK, which lead
  to tumor cell proliferation. Moreover, IDH mutations later Krebs cycle in mitochondria,
  which further alter activity of downstream epigenetic regulators, including TET1/2
  and KDM, leading to methylation alterations for DNA and nucleosome states susceptible
  to for tumorigenesis. GBM, glioblastoma; NSCs, neural stem cells; NPC, neuron progenitor
  cell; APC, astrocyte progenitor cell; OPC, oligodendrocyte progenitor cell; RTK,
  receptor tyrosine kinase; MYC, myelocytomatosis viral oncogene; AURK, aurora kinase;
  IDH, Isocitrate dehydrogenase; TET, Tet oncogene; KDM, lysine(K)-specific demethylase.
pmcid: PMC6565468
papertitle: Convergence of Developmental Origins and Oncogenic Pathways in Malignant
  Brain Tumors.
reftext: Q. Richard Lu, et al. Wiley Interdiscip Rev Dev Biol. ;8(4):e342-e342.
pmc_ranked_result_index: '45088'
pathway_score: 0.8569638
filename: nihms-1021454-f0002.jpg
figtitle: Convergence of Developmental Origins and Oncogenic Pathways in Malignant
  Brain Tumors
year: ''
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6565468__nihms-1021454-f0002.html
  '@type': Dataset
  description: A) Multipotent NSCs have capability to self-renew and differentiate
    into different fate-restricted progenitors. Under genetic and epigenetic alterations,
    these progenitor cells could be transformed into malignant tumors including gliomas
    from NSC, OPC or APC as well as medulloblastomas from NPCs.B) A hierarchical model
    for tumor cell evolution and plasticity to generate distinct tumor-forming cells
    and tumor heterogeneity gained after tumor initiation.C) Malignant transformation
    of GBM is the result of different driver pathway alterations. RTK signaling pathway
    activation mediated by extracellular signal (growth factors, cytokines, and hormones)
    promotes cell cycling for tumorigenesis. Besides, point mutation of histone 3
    (H3K27M, H3G34R/V) and up-regulation of oncogenic factors, like MYC(N) and AURK,
    which lead to tumor cell proliferation. Moreover, IDH mutations later Krebs cycle
    in mitochondria, which further alter activity of downstream epigenetic regulators,
    including TET1/2 and KDM, leading to methylation alterations for DNA and nucleosome
    states susceptible to for tumorigenesis. GBM, glioblastoma; NSCs, neural stem
    cells; NPC, neuron progenitor cell; APC, astrocyte progenitor cell; OPC, oligodendrocyte
    progenitor cell; RTK, receptor tyrosine kinase; MYC, myelocytomatosis viral oncogene;
    AURK, aurora kinase; IDH, Isocitrate dehydrogenase; TET, Tet oncogene; KDM, lysine(K)-specific
    demethylase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - APC
  - HGF
  - EGF
  - PDGFA
  - PDGFB
  - MET
  - EGFR
  - PDGFRB
  - PDGFRA
  - IGF1R
  - NF1
  - HRAS
  - KRAS
  - NRAS
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - IDH2
  - IDH1
  - MTOR
  - AKT2
  - AKT3
  - AKT1
  - CDK6
  - CDK4
  - MDM2
  - E2F3
  - E2F8
  - E2F1
  - E2F2
  - E2F4
  - E2F5
  - E2F6
  - E2F7
  - OLIG2
  - TET1
  - TET2
  - CDK2
  - CDK1
  - MYCN
  - Citrate
  - Isocitrate
  - 'N'
  - cancer
  - Tumor Oligodendrocyte Tumor
genes:
- word: АРС
  symbol: APC
  source: hgnc_symbol
  hgnc_symbol: APC
  entrez: '324'
- word: HGF
  symbol: HGF
  source: hgnc_symbol
  hgnc_symbol: HGF
  entrez: '3082'
- word: EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: PDGF-A/B
  symbol: PDGF-A
  source: hgnc_alias_symbol
  hgnc_symbol: PDGFA
  entrez: '5154'
- word: PDGF-A/B
  symbol: PDGFB
  source: hgnc_symbol
  hgnc_symbol: PDGFB
  entrez: '5155'
- word: MET
  symbol: MET
  source: hgnc_symbol
  hgnc_symbol: MET
  entrez: '4233'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: PDGFR
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRB
  entrez: '5159'
- word: PDGFR
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRA
  entrez: '5156'
- word: IGFR
  symbol: IGFR
  source: hgnc_alias_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: NF1
  symbol: NF1
  source: hgnc_symbol
  hgnc_symbol: NF1
  entrez: '4763'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: IDH2
  symbol: IDH2
  source: hgnc_symbol
  hgnc_symbol: IDH2
  entrez: '3418'
- word: IDH1
  symbol: IDH1
  source: hgnc_symbol
  hgnc_symbol: IDH1
  entrez: '3417'
- word: IDH2
  symbol: IDH2
  source: hgnc_symbol
  hgnc_symbol: IDH2
  entrez: '3418'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: IDH1
  symbol: IDH1
  source: hgnc_symbol
  hgnc_symbol: IDH1
  entrez: '3417'
- word: Cdk4/6
  symbol: CDK6
  source: hgnc_symbol
  hgnc_symbol: CDK6
  entrez: '1021'
- word: Cdk4/6
  symbol: CDK4
  source: hgnc_symbol
  hgnc_symbol: CDK4
  entrez: '1019'
- word: MDM2
  symbol: MDM2
  source: hgnc_symbol
  hgnc_symbol: MDM2
  entrez: '4193'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F3
  entrez: '1871'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F8
  entrez: '79733'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F1
  entrez: '1869'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F2
  entrez: '1870'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F4
  entrez: '1874'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F5
  entrez: '1875'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F6
  entrez: '1876'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F7
  entrez: '144455'
- word: Olig2
  symbol: OLIG2
  source: hgnc_symbol
  hgnc_symbol: OLIG2
  entrez: '10215'
- word: PDGFR.
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRB
  entrez: '5159'
- word: PDGFR.
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRA
  entrez: '5156'
- word: TET1/2
  symbol: TET1
  source: hgnc_symbol
  hgnc_symbol: TET1
  entrez: '80312'
- word: TET1/2
  symbol: TET2
  source: hgnc_symbol
  hgnc_symbol: TET2
  entrez: '54790'
- word: Cdk2
  symbol: CDK2
  source: hgnc_symbol
  hgnc_symbol: CDK2
  entrez: '1017'
- word: CDK1
  symbol: CDK1
  source: hgnc_symbol
  hgnc_symbol: CDK1
  entrez: '983'
- word: Cdk2
  symbol: CDK2
  source: hgnc_symbol
  hgnc_symbol: CDK2
  entrez: '1017'
- word: MYC(N),
  symbol: MYCN
  source: hgnc_symbol
  hgnc_symbol: MYCN
  entrez: '4613'
- word: CDK1
  symbol: CDK1
  source: hgnc_symbol
  hgnc_symbol: CDK1
  entrez: '983'
chemicals:
- word: Citrate
  source: MESH
  identifier: C102006
- word: Isocitrate
  source: MESH
  identifier: D007523
- word: 'N'
  source: MESH
  identifier: D009584
diseases:
- word: cancer
  source: MESH
  identifier: D009369
- word: Tumor Oligodendrocyte Tumor
  source: MESH
  identifier: D009369
figid_alias: PMC6565468__F1
redirect_from: /figures/PMC6565468__F1
figtype: Figure
---
